Mevociclib

CAS No. 1816989-16-8

Mevociclib ( SY-1365 )

Catalog No. M26471 CAS No. 1816989-16-8

Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 262 Get Quote
50MG 1485 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Mevociclib
  • Note
    Research use only, not for human use.
  • Brief Description
    Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.
  • Description
    Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.
  • Synonyms
    SY-1365
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    Akt; caspase-3; JNK1; p44/42 MAPK; RhoGDI
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1816989-16-8
  • Formula Weight
    587.1
  • Molecular Formula
    C31H35ClN8O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C)C\C=C\C(=O)Nc1ccc(nc1)C(=O)N[C@@]1(C)CCC[C@H](C1)Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kohno K, Ohashi E, et al. Anti-inflammatory effects of adenosine N1-oxide. J Inflamm (Lond). 2015 Jan 20;12(1):2.
molnova catalog
related products
  • CID44216842

    CID44216842 is a potent Cdc42-selective guanine nucleotide binding lead inhibitor.?

  • THZ-1 hydrochloride

    THZ-1 hydrochloride is a potent, selective, covalent CDK7 inhibitor with IC50 of 3.2 nM; also weakly inhibits CDK12 with IC50 of 250 nM.

  • AT-7519

    A potent CDK2 inhibitor with IC50 of 47 nM; also inhibits CDK1/4/5 with IC50 of 190/67/18 nM and shows selectivity over some kinases (Aurora A, IR kinase, MEK, PDK1, c-Abl, IC50>10 uM).